SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel Guidance.

IF 2.3 2区 医学 Q2 OPHTHALMOLOGY
Charles C Wykoff, Robert L Avery, Mark R Barakat, David S Boyer, David M Brown, Alexander J Brucker, Emmett T Cunningham, Jeffrey S Heier, Nancy M Holekamp, Peter K Kaiser, Arshad M Khanani, Judy E Kim, Hakan Demirci, Carl D Regillo, Glenn C Yiu, Thomas A Ciulla
{"title":"SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel Guidance.","authors":"Charles C Wykoff, Robert L Avery, Mark R Barakat, David S Boyer, David M Brown, Alexander J Brucker, Emmett T Cunningham, Jeffrey S Heier, Nancy M Holekamp, Peter K Kaiser, Arshad M Khanani, Judy E Kim, Hakan Demirci, Carl D Regillo, Glenn C Yiu, Thomas A Ciulla","doi":"10.1097/IAE.0000000000004087","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To develop professional guidelines for best practices for suprachoroidal space (SCS) injection, an innovative technique for retinal therapeutic delivery, based on current published evidence and clinical experience.</p><p><strong>Methods: </strong>A panel of expert ophthalmologists reviewed current published evidence and clinical experience during a live working group meeting to define points of consensus and key clinical considerations to inform the development of guidelines for in-office SCS injection.</p><p><strong>Results: </strong>Core consensus guidelines for in-office SCS injection were reached and reported by the expert panel. Current clinical evidence and physician experience supported SCS injection as a safe and effective method for delivering retinal and choroidal therapeutics. The panel established consensus on the rationale for SCS injection, including potential benefits relative to other intraocular delivery methods and current best practices in patient preparation, pre- and peri-injection management, SCS-specific injection techniques, and postinjection management and follow-up.</p><p><strong>Conclusion: </strong>These expert panel guidelines may support and promote standardization of SCS injection technique, with the goal of optimizing patient safety and outcomes. Some aspects of the procedure may reasonably be modified based on the clinical setting and physician judgment, as well as additional study.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina-The Journal of Retinal and Vitreous Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IAE.0000000000004087","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To develop professional guidelines for best practices for suprachoroidal space (SCS) injection, an innovative technique for retinal therapeutic delivery, based on current published evidence and clinical experience.

Methods: A panel of expert ophthalmologists reviewed current published evidence and clinical experience during a live working group meeting to define points of consensus and key clinical considerations to inform the development of guidelines for in-office SCS injection.

Results: Core consensus guidelines for in-office SCS injection were reached and reported by the expert panel. Current clinical evidence and physician experience supported SCS injection as a safe and effective method for delivering retinal and choroidal therapeutics. The panel established consensus on the rationale for SCS injection, including potential benefits relative to other intraocular delivery methods and current best practices in patient preparation, pre- and peri-injection management, SCS-specific injection techniques, and postinjection management and follow-up.

Conclusion: These expert panel guidelines may support and promote standardization of SCS injection technique, with the goal of optimizing patient safety and outcomes. Some aspects of the procedure may reasonably be modified based on the clinical setting and physician judgment, as well as additional study.

脉络膜上腔注射技术:专家组指南。
目的:根据目前已发表的证据和临床经验,为脉络膜上腔(SCS)注射这一视网膜治疗创新技术的最佳实践制定专业指南:一个由眼科专家组成的小组在一次现场工作组会议上审查了当前已发表的证据和临床经验,以确定共识点和关键临床考虑因素,为制定诊室内 SCS 注射指南提供依据:结果:专家小组就诊室内注射 SCS 的核心指导原则达成了共识并进行了报告。目前的临床证据和医生经验都支持将 SCS 注射作为一种安全有效的视网膜和脉络膜治疗方法。专家组就 SCS 注射的理由达成了共识,包括相对于其他眼内给药方法的潜在益处,以及当前在患者准备、注射前和注射周围管理、SCS 特定注射技术、注射后管理和随访方面的最佳实践:这些专家小组指南可支持和促进 SCS 注射技术的标准化,从而优化患者安全和治疗效果。程序的某些方面可根据临床环境和医生的判断以及需要进一步研究的领域进行合理修改。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.70
自引率
9.10%
发文量
554
审稿时长
3-6 weeks
期刊介绍: ​RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice. In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color. Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信